Vials labeled “COVID-19 Coronavirus Vaccine” and syringe are seen in front of shown Johnson & Johnson symbol in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/File Image

JOHANNESBURG, Dec 23 (Reuters) – South Africa’s overall health regulator on Thursday approved the use of Johnson & Johnson (JNJ.N) vaccine for a next dose or booster, paving the way for the shot broadly applied in South Africa to shore up protection from the Omicron variant.

The place previously declared in December that it was preparing to present folks booster doses of equally the Pfizer (PFE.N) and J&J pictures, but it did not specify when J&J boosters would be available.

The South African Wellbeing Products and solutions Authority (SAPHRA) reported in a assertion on Thursday that it experienced approved J&J shots for use as a 2nd dose or booster at the very least two months just after the completion of the person’s most important vaccination, with both J&J’s single-shot training course or an additional accredited mRNA COVID-19 vaccine.

J&J boosters have so far only been accessible for health staff, even though Pfizer boosters are set to be introduced from January for individuals who experienced their next dose six months ago or far more.

South Africa has relied greatly on the two companies’ pictures in its vaccination campaign, which experienced provided 44% of its adult population at the very least one dose of a COVID-19 vaccine earlier this thirty day period.

That is a lot more than lots of African international locations, but perfectly short of the government’s year-close goal.

Reporting by Emma RumneyEditing by Elaine Hardcastle

Our Expectations: The Thomson Reuters Belief Ideas.